What to know
- VEHSS includes indicators on the percentage of people with diagnosed AMD who had a treatment claim from payment claims in administrative claims databases and medical record information in the IRIS Registry of electronic health records.
- VEHSS reports the percent of patients diagnosed with AMD who received at least one included treatment during the year of observation.
- Therefore, all prevalence estimates are based on a denominator of patients who had a visit during the calendar year that included an AMD diagnosis.
Anti–vascular endothelial growth factor (Anti-VEGF) injection
Anti-VEGF injection procedures are identified among patients with diagnosed AMD based on the procedure, diagnosis, and national drug codes (NDC) listed below.
Included Procedures
Procedure, Diagnosis and NDC Codes
Injection, aflibercept
J0178, J9400
Injection, ranibizumab
J2778
Injection, bevacizumab, unclassified injectable, or compounded drug
J9035, J3490, J3590, J7999, C9257, C9142, Q5107, or Q9977 AND claim has primary diagnosis of AMD OR includes 67028
Intravitreal injection of pharmacologic agent
67028 with anti-VEGF NDC (61755-005-02, 61755-005-55, 50242-080-02, 50242-0080-02, 50242-080-03, 50242-0080-03, 50242-060-01, 50242-060-10)
Explore Data in the VEHSS Application
Laser/photocoagulation therapy
Laser/photocoagulation therapy procedures are identified among patients with diagnosed AMD based on the procedure and diagnosis codes listed below.
- Included Procedures - Destruction procedures on the retina or choroid, photocoagulation
- Procedure Codes - 67220 or G0186
The data sources available for this category include Medicare (default), IRIS Registry, Medicaid, Managed Vision Care, and MarketScan commercial insurance claims.
Explore Data in the VEHSS Application
Photodynamic therapy
Photodynamic therapy procedures are identified among patients with diagnosed AMD based on the procedure and diagnosis codes listed below.
Included Procedures
Procedure Codes
Destruction procedures on the retina or choroid, photodynamic therapy
67221
Destruction procedures on the retina or choroid, photodynamic therapy, second eye
67225
Verteporfin injection
J3396